{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:00:47Z","timestamp":1762297247765,"version":"3.44.0"},"reference-count":30,"publisher":"BMJ","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1994,7]]},"abstract":"<jats:p>Although ulcers are often associated with non-steroidal anti-inflammatory drugs (NSAIDs) little is known about the feasibility of predicting their development in patients taking NSAIDs. In addition, the ulcerogenic potentials of the newer NSAIDs, taken on long term basis, have not been compared with those of more established preparations. The aim of this study was to identify the clinical and pathological characteristics of patients at a higher risk of NSAID induced ulcers, measure the ulcerogenic potential of a variety of NSAIDs, and test the effect of these potentials on the predictability of ulceration. Altogether 190 long term NSAID users were studied. The presence of abdominal complaints, previous history of ulcers, arthritis related physical disability, anaemia, gastritis, and Helicobacter pylori status were all assessed as possible risk factors. NSAIDs were classified into established drugs (group I), and newer agents (group II). Group I included naproxen, indomethacin, diclofenac, ketoprofen, piroxicam, and flurbiprofen. Group II included fenbufen, nabumetone, ibuprofen, etodolac, azapropazone, and tiaprofenic acid. Of 63 ulcers identified in the study group, 51 (81%) were seen in group I NSAID patients (51 of 132, 39%) compared with 12 ulcers in group II (12 of 58, 21%), p &lt; 0.02; estimated relative risk (ERR): 2.41). In group I, 25 ulcers were found in 38 patients with abdominal pain (25 of 38, 66%, p &lt; 0.01, ERR: 5.03); 18 in 25 (72%) patients with a previous history of ulcers (p &lt; 0.001, ERR: 5.77), 26 in 44 (59%) patients with debilitating arthritis (p &lt; 0.001, ERR 3.64), and 35 in 73 (48%) patients with H pylori associated gastritis (p &lt; 0.01, ERR: 2.48). The presence of these factors in group II patients did not influence the risk of ulceration. Group I NSAIDs were more likely to be associated with chemical gastritis and to intensify H pylori related damage. Although silent ulcers are not uncommon in patients taking NSAIDs, recognition of the risk factors might helps predict a significant number (up to 81%), especially in those receiving group I NSAIDs.<\/jats:p>","DOI":"10.1136\/gut.35.7.891","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"891-895","source":"Crossref","is-referenced-by-count":32,"title":["Predicting NSAID related ulcers--assessment of clinical and pathological risk factors and importance of differences in NSAID."],"prefix":"10.1136","volume":"35","author":[{"given":"A S","family":"Taha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Dahill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R D","family":"Sturrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F D","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R I","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1994,7,1]]},"reference":[{"key":"ref_1","first-page":"1349","article-title":"Do young patients with dyspepsia need investigation?","volume":"ii:","author":"Williams, B.; Luckas, M.; Ellingham, J.H.M.; Dain, A.; Wicks, A.C.B.","year":"1988","unstructured":"Williams B, Luckas M, Ellingham JHM, Dain A, Wicks ACB. Do young patients with dyspepsia need investigation? Lancet 1988; ii: 1349-51.","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/bmj.301.6751.513","article-title":"Early detection of gastric cancer","volume":"301","author":"Hallissey, M.T.; Allum, W.H.; Jewkes, A.J.; Ellis, D.J.; Fielding, J.W.L.","year":"1990","unstructured":"Hallissey MT, Allum WH, Jewkes AJ, Ellis DJ, Fielding JWL. Early detection of gastric cancer. BMJ 1990; 301: 513-15.","journal-title":"BMJ"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/bmj.287.6397.937","article-title":"Scoring system to improve effectiveness of open access endoscopy","volume":"287","author":"Mann, J.; Holdstock, G.; Harman, M.; Machin, D.; Lohry, C.A.","year":"1983","unstructured":"Mann J, Holdstock G, Harman M, Machin D, Lohry CA. Scoring system to improve effectiveness of open access endoscopy. BMJ 1983; 287: 937-40.","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/bmj.290.6463.217","article-title":"Can preliminary screening of dyspeptic patients allow more effective use of investigational techniques?","volume":"290","author":"Davenport, P.M.; Morgan, A.G.; Damborough, A.; Dombal, De","year":"1985","unstructured":"Davenport PM, Morgan AG, Damborough A, De Dombal Fr. Can preliminary screening of dyspeptic patients allow more effective use of investigational techniques? BMJ 1985; 290: 217-19.","journal-title":"BMJ"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/0016-5085(86)90381-1","article-title":"Prospective testing of a scoring system designed to improve case selection for upper gastrointestinal investigation","volume":"90","author":"Holdstock, G.; Harman, M.; Machin, D.; Patel, C.; Lloyd, R.S.","year":"1986","unstructured":"Holdstock G, Harman M, Machin D, Patel C, Lloyd RS. Prospective testing of a scoring system designed to improve case selection for upper gastrointestinal investigation. Gastroenterology 1986; 90: 1164-69.","journal-title":"Gastroenterology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0140-6736(91)90085-4","article-title":"Screening dyspepsia by serology to Helicobacter pylori","volume":"338","author":"Sobala, G.M.; Crabtree, J.E.; Pentith, J.A.; Rathbone, B.J.; Shallcross, T.M.; Wyatt, J.I.","year":"1991","unstructured":"Sobala GM, Crabtree JE, Pentith JA, Rathbone BJ, Shallcross TM, Wyatt JI, et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991; 338: 94-6.","journal-title":"Lancet"},{"key":"ref_7","first-page":"577","article-title":"Helicobacter pylori and the endoscopist: whether to diagnose Gastrointest Endosc","volume":"37","author":"Graham, D.Y.","year":"1991","unstructured":"Graham DY. Helicobacter pylori and the endoscopist: whether to diagnose Gastrointest Endosc 1991; 37: 577-9."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bmj.297.6652.833","article-title":"Non-steroidal anti-inflammatory drugs and pain-free peptic ulceration in the elderly","volume":"297","author":"Skander, M.P.; Ryan, F.P.","year":"1988","unstructured":"Skander MP, Ryan FP. Non-steroidal anti-inflammatory drugs and pain-free peptic ulceration in the elderly. BMJ 1988; 297: 833-4.","journal-title":"BMJ"},{"key":"ref_9","first-page":"1588","article-title":"Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs","volume":"86","author":"Taha, A.S.; Capell, H.A.; Sturrock, R.D.; Russell, R.I.","year":"1991","unstructured":"Taha AS, Capell HA, Sturrock RD, Russell RI. Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs. Am J Gastroenteral 1991; 86: 1588-9 1.","journal-title":"Am J Gastroenteral"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/gut.34.4.461","article-title":"Serological diagnosis of Helicobacter pylori. Evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs","volume":"34","author":"Taha, A.S.; Reid, J.; Boothman, P.; Gemmell, C.G.; Lee, F.D.; Sturrock, R.D.; Russell, R.I.","year":"1993","unstructured":"Taha AS, Reid J, Boothman P, Gemmell CG, Lee FD, Sturrock RD, Russell RI. Serological diagnosis of Helicobacter pylori. Evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs. Gut 1993; 34: 461-5.","journal-title":"Gut"},{"key":"ref_11","first-page":"5","article-title":"Do differential rates of NSAID-associated gastroduodenal damage exist? The results of a large cohort endoscopy study carried out in RA and OA patients","volume":"29","author":"Shield, M.J.; Fenn, G.C.; Kiff, P.; Stead, H.; Gies, S.","year":"1990","unstructured":"Shield MJ, Fenn GC, Kiff P, Stead H, Gies S. Do differential rates of NSAID-associated gastroduodenal damage exist? The results of a large cohort endoscopy study carried out in RA and OA patients. BrJf Rheumatol 1990; 29 (suppl): 5.","journal-title":"BrJf Rheumatol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/rheumatology\/28.4.329","article-title":"McLaughlin 5, Sturrock RD, Russell RI. Evaluation of the efficacy and comparative effects on gastric and duodenal mucosa of etodolac and naproxen in patients with rheumatoid arthritis using endoscopy","volume":"28","author":"Tabs AS","year":"1989","unstructured":"Tabs AS, McLaughlin 5, Sturrock RD, Russell RI. Evaluation of the efficacy and comparative effects on gastric and duodenal mucosa of etodolac and naproxen in patients with rheumatoid arthritis using endoscopy. Br Jf Rheumatol 1989; 28: 329-32.","journal-title":"Br Jf Rheumatol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/00365528909091171","article-title":"A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs","volume":"163","author":"Lanza, F.L.","year":"1989","unstructured":"Lanza FL. A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs. Scand Jf Gastroenterol 1989; 24 (Suppl 163): 24-31.","journal-title":"Scand Jf Gastroenterol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/rheumatology\/32.2.135","article-title":"The Health Assessment Questionnaire as a predictor of non-steroidal peptic ulceration","volume":"32","author":"Taha, A.S.; Morran, C.; Sturrock, R.D.; Russell, R.I.","year":"1993","unstructured":"Taha AS, Morran C, Sturrock RD, Russell RI. The Health Assessment Questionnaire as a predictor of non-steroidal peptic ulceration. BrJ Rheumatol 1993; 32: 135-8.","journal-title":"BrJ Rheumatol"},{"key":"ref_15","first-page":"47","article-title":"Gastric mucosal prostaglandin synthesis in the presence of Campylobacter pylori in patients with gastric ulcers and non-ulcer dyspepsia","volume":"85","author":"Taha, A.S.; Boothman, P.; Holland, P.; McKinley, A.W.; Uphadyay, R.; Kelly, R.W.; Russell, R.I.","year":"1990","unstructured":"Taha AS, Boothman P, Holland P, McKinley AW, Uphadyay R, Kelly RW, Russell RI. Gastric mucosal prostaglandin synthesis in the presence of Campylobacter pylori in patients with gastric ulcers and non-ulcer dyspepsia. Am Jf Gastroenterol 1990; 85: 47-50.","journal-title":"Am Jf Gastroenterol"},{"key":"ref_16","first-page":"1","article-title":"The Sydney system: a new classification of gastritis. In: Working Party Reports of the World Congress of Gastroenterology","author":"Misiewicz, J.I.; Tytgat, G.N.J.; Price, Goodwin C.S.; AB, Sipponen; P, Strickland; R.G.","year":"1990","unstructured":"Misiewicz JI, Tytgat GNJ, Goodwin CS Price AB, Sipponen P, Strickland RG, et al. The Sydney system: a new classification of gastritis. In: Working Party Reports of the World Congress of Gastroenterology. Oxford: Blackwell Scientific Publications 1990: 1-10."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/jcp.39.5.524","article-title":"Reflux gastritis: distinct histopathological entity","volume":"39","author":"Dixon, M.F.; O'Connor, H.J.; Axon, A.T.R.; King, R.F.J.G.; Johnston, D.","year":"1986","unstructured":"Dixon MF, O'Connor HJ, Axon ATR, King RFJG, Johnston D. Reflux gastritis: distinct histopathological entity. Jf Clin Pathol 1986; 39: 524-30.","journal-title":"Jf Clin Pathol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jcp.43.4.303","article-title":"Reflux gastritis in the intact stomach","volume":"43","author":"Sobala, G.M.; King, R.F.G.; Axon, A.T.R.; Dixon, M.F.","year":"1990","unstructured":"Sobala GM, King RFG, Axon ATR, Dixon MF. Reflux gastritis in the intact stomach. Jf Clin Pathol 1990; 43: 303-6.","journal-title":"Jf Clin Pathol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jcp.45.2.135","article-title":"Chemical gastritis and Helicobacter pylori - related gastritis in patients receiving non-steroidal anti-inflammatory drugs. Comparison and correlation with peptic ulceration","volume":"45","author":"Taha, A.S.; Nakshabendi, I.; Lee, F.D.; Sturrock, R.D.; Russell, R.I.","year":"1992","unstructured":"Taha AS, Nakshabendi I, Lee FD, Sturrock RD, Russell RI. Chemical gastritis and Helicobacter pylori - related gastritis in patients receiving non-steroidal anti-inflammatory drugs. Comparison and correlation with peptic ulceration. Jf Clin Pathol 1992; 45: 135-9.","journal-title":"Jf Clin Pathol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/path.1711540204","article-title":"Lymphocytic gastritis - relationship to Campylobacter pylori infection","volume":"154","author":"Dixon, M.F.; Wyatt, J.; Burk, D.A.; Rathbone, B.J.","year":"1988","unstructured":"Dixon MF, Wyatt J, Burk DA, Rathbone BJ. Lymphocytic gastritis - relationship to Campylobacter pylori infection. JPathol 1988; 154: 125-32.","journal-title":"JPathol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.280.6207.75","article-title":"Gastroscopic evaluation of antiinflammatory agents","volume":"280","author":"Caruso, I.; Bianchi-Porro, G.","year":"1980","unstructured":"Caruso I, Bianchi-Porro G. Gastroscopic evaluation of antiinflammatory agents. BMJ 1980; 280: 75-8.","journal-title":"BMJ"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/gut.26.4.359","article-title":"Non-steroidal anti-inflammatory drugs and peptic ulcer perforation","volume":"26","author":"Collier, D.S.J.; Pain, J.A.","year":"1985","unstructured":"Collier DSJ, Pain JA. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985; 26: 359-63.","journal-title":"Gut"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/gut.28.5.527","article-title":"Non-steroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration","volume":"28","author":"Armstrong, C.P.; Blower, A.L.","year":"1987","unstructured":"Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration. Gut 1987; 28: 527-32.","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(86)92927-2","article-title":"Non-steroidal antiinflammatory drugs and bleeding peptic ulcer","volume":"i:","author":"Somerville, K.; Faulkner, G.; Langman, M.","year":"1986","unstructured":"Somerville K, Faulkner G, Langman M. Non-steroidal antiinflammatory drugs and bleeding peptic ulcer. Lancet 1986; i: 462-64.","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1136\/bmj.297.6655.1017","article-title":"Prevention of gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs: controlled trial of ranitidine","volume":"297","author":"Ehsanullah, R.S.B.; Page, M.C.; Tidesley, G.; Wood, JR","year":"1988","unstructured":"Ehsanullah RSB, Page MC, Tidesley G, Wood JR. Prevention of gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ 1988; 297: 1017-21.","journal-title":"BMJ"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00325481.1991.11700937","article-title":"Non steroidal anti-inflammatory drugs and peptic ulcer disease. An overview","volume":"89","author":"Silverstein, F.","year":"1991","unstructured":"Silverstein F. Non steroidal anti-inflammatory drugs and peptic ulcer disease. An overview. Postgrad Med 1991; 89: 33-40.","journal-title":"Postgrad Med"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2036.1993.tb00067.x","article-title":"Gastric and duodenal mucosal blood flow in patients receiving nonsteroidal anti-inflammatory drugs - influence of age, smoking, ulceration and Helicobacter pylori","volume":"7","author":"Taha, A.S.; Angerson, W.; Nakshabendi, I.; Beekman, H.; Morran, C.; Sturrock, R.D.; Russell, R.I.","year":"1993","unstructured":"Taha AS, Angerson W, Nakshabendi I, Beekman H, Morran C, Sturrock RD, Russell RI. Gastric and duodenal mucosal blood flow in patients receiving nonsteroidal anti-inflammatory drugs - influence of age, smoking, ulceration and Helicobacter pylori. Aliment Pharmacol Therap 1993; 7: 41-5.","journal-title":"Aliment Pharmacol Therap"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/ard.49.6.354","article-title":"Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis","volume":"49","author":"Taha, A.S.; McLaughlin, S.; Holland, P.J.; Kelly, R.W.; Sturrock, R.D.; Russell, R.I.","year":"1990","unstructured":"Taha AS, McLaughlin S, Holland PJ, Kelly RW, Sturrock RD, Russell RI. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis. Ann Rheum Dis 1990; 49: 354-8.","journal-title":"Ann Rheum Dis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/0016-5085(91)90665-8","article-title":"Long-term non-steroidal anti-inflammatory drug use and Helicobacter pylori infection","volume":"100","author":"Graham, D.Y.; Lidsky, M.D.; Cox, A.M.; DJ, Jr, Evans; Evans, D.G.; Alpert, L.","year":"1991","unstructured":"Graham DY, Lidsky MD, Cox AM, Evans DJ Jr, Evans DG, Alpert L, et al. Long-term non-steroidal anti-inflammatory drug use and Helicobacter pylori infection. Gastroenterology 1991; 100: 1653-7.","journal-title":"Gastroenterology"},{"key":"ref_30","first-page":"1899","article-title":"Long-term non-steroidal anti-inflammatory drug use and gastrointestinal injury: the role","volume-title":"of Helicobacter pylori. Gastroenterology 1992; 102","author":"Loeb, D.S.; Talley, N.J.; Ahlquist, D.A.; Carpenter, H.A.; Zinsmeister, A.R.","unstructured":"Loeb DS, Talley NJ, Ahlquist DA, Carpenter HA, Zinsmeister AR. Long-term non-steroidal anti-inflammatory drug use and gastrointestinal injury: the role of Helicobacter pylori. Gastroenterology 1992; 102: 1899-1905."}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.35.7.891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T19:13:24Z","timestamp":1757272404000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.35.7.891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,7]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[1994,7,1]]},"published-print":{"date-parts":[[1994,7]]}},"alternative-id":["10.1136\/gut.35.7.891"],"URL":"https:\/\/doi.org\/10.1136\/gut.35.7.891","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"type":"print","value":"0017-5749"},{"type":"electronic","value":"1468-3288"}],"subject":[],"published":{"date-parts":[[1994,7]]}}}